IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Boxer Capital, LLC

Q4 2016 Holdings

Filed 2017-02-14 | 28 holdings | $36.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Beigene LTD(ONC)SPONSORED ADR07725L102$25.8M850,00069.8%
Alnylam Pharmaceuticals Inc(ALNY)COM02043Q107$9.4M250,00025.3%
Aldeyra Therapeutics Inc(ALDX)COM01438T106$1.6M291,2304.2%
Avexis IncCOM05366U100$49.1K1,028,7630.1%
Clovis Oncology Inc(CLVSEUR)COM189464100$37.8K850,0000.1%
Medicines CoCOM584688105$28.1K828,1980.1%
Medicines CoCallCALL584688905$21.3K627,4000.1%
Blueprint Medicines Corp(2L9)COM09627Y109$19.8K705,1590.1%
Aquinox Pharmaceuticals IncCOM03842B101$14.5K877,7530.0%
Incyte Corp(INCY)COM45337C102$10.0K100,0000.0%
Alexion Pharmaceuticals Inc(ALXN)COM015351109$9.2K75,0000.0%
Seattle Genetics IncCOM812578102$5.3K100,0000.0%
Tesaro IncCOM881569107$4.7K35,0000.0%
Mirati Therapeutics Inc(MRTXEUR)COM60468T105$3.6K757,9350.0%
Kura Oncology Inc(KURA)COM50127T109$3.1K533,2510.0%
Strongbridge Biopharma PLCSHS USDG85347105$2.3K940,0000.0%
Sunesis Pharmaceuticals IncCOM PAR867328700$1.9K525,0000.0%
Array Biopharma Inc(ARRYEUR)COM04269X105$1.8K200,0000.0%
Syndax Pharmaceuticals Inc(SNDX)COM87164F105$1.7K234,2200.0%
Eiger Biopharmaceuticals Inc(CLDNEUR)COM28249U105$1.6K138,3310.0%
Nabriva Therapeutics AGSPONSORED ADR62957M104$1.1K176,7100.0%
Aradigm Corp(ARDMEUR)COM NO PAR NEW038505400$1.0K634,7080.0%
Akari Therapeutics PLCSPONSORED ADR00972G108$985139,8990.0%
Bellerophon Therapeutics Inc(BLPHEUR)COM078771102$9661,857,1430.0%
Onconova Therapeutics IncCOM NEW68232V306$718316,3800.0%
Ignyta IncCOM451731103$663125,0000.0%
Nexvet Biopharma PUB LTD CoORD SHSG6503X109$578154,8400.0%
Onconova Therapeutics Inc*W EXP 07/07/20268232V116$150241,6440.0%